Use Acura Pharmaceuticals Inc. management performance with your portfolios to protect against small markets fluctuations as well as to determine Stock diversification method that is right for you.
Acura Management Effectiveness
The company has return on total asset (ROA) of 23.93 % which means that it generated profit of $23.93 on every $1 spent on asset. This is very large. Similarly, it shows return on stockholders equity (ROE) of 39.19 % meaning that it created $39.19 on every dollar invested by stockholders.
Acura Profit Margins
The company has Profit Margin (PM) of 53.92 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 54.49 % which suggests for every dolor of sales it generated a net operating income of 0.54.
Acura Insiders
Robert Jones Chief Executive officer and President and Director, MBA
Robert Seiser VP, Treasurer and Corporate Controller
Acura Pharmaceuticals Inc. Workforce
Acura Pharmaceuticals Inc. is rated below average in number of employees category among related companies. The total workforce of Drug Delivery industry is presently estimated at about 23,621. Acura adds roughly 15.0 in number of employees claiming only tiny portion of equities under Drug Delivery industry.
Chief Executive officer and President and Director
Mr. Robert B. Jones serves as President, Chief Executive Officer, Director of Acura Pharmaceuticals, Inc., effective July 7, 2011. He was the company President and Chief Executive Officer since July 7, 2011. ...
Mr. Richard J. Markham is Chairman of the Board of Acura Pharmaceuticals, Inc. Since November, 2004 Mr. Markham was a member of the company Board of Directors since May, 2006. Since November, 2004 Mr. ...
Acura employes about 15 people. The company is managed by 14 executives with total tenure of roughly 55 years, averanging almost 3.0 years of service per executive having 1.0 employee per reported executive.
Return on Acura Manpower
Revenue Per Employee
1.3 M
Revenue Per Executive
1.4 M
Net Income Per Employee
727.3 K
Net Income Per Executive
779.3 K
Working Capital Per Employee
2.2 M
Working Capital Per Executive
2.3 M
Acura Earnings Per Share
According to company disclosure Acura Pharmaceuticals Inc. has Earnings Per Share of 0.23 times. This is 78.5% lower than that of Healthcare sector, and 55.77% lower than that of Drug Delivery industry, The Earnings Per Share for all stocks is 84.87% higher than the company.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
